tiprankstipranks
Trending News
More News >

Pat Beyer Insider Profile

4 Followers
Pat Beyer, President & CEO at Conmed, holds 10.81K shares in Conmed (Ticker: CNMD), holds ― shares in Misonix (Ticker: MSON), holds 76.44K shares in Bioventus (Ticker: BVS). Most recently, Pat Beyer Bought ― shares of Conmed on May 02, 2024 for an estimated value of $204.90K.
tipranks
Pat Beyer

Pat Beyer
Conmed (CNMD)
President & CEO

Ranked #25,644 out of 103,431 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

+15.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
51.21%
48.79%
A breakdown of Pat Beyer's holdings

Insider Roles

Conmed
(CNMD)
President & CEO
Bioventus
(BVS)
Director
Roles that Pat Beyer holds in companies

Most Profitable Insider Trade

Stock:
Conmed
(CNMD)
Rating:Informative Sell
Date:Nov 05, 2021 - Nov 05, 2022
Return:+51.10%
The most profitable trade made by Pat Beyer

Pat Beyer's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Conmed
May 02, 2024
President & CEO
Informative Buy
204.90K
$583.36K
MSON
Misonix
Bioventus
Jun 04, 2025
Director
Uninformative Buy
170.61K
$555.69K
List of latest transactions for each holding click on a transaction to see Pat Beyer's performance on stock

Pat Beyer insider profile FAQ

What is the percentage of profitable transactions made by Pat Beyer?
The percentage of profitable transactions made by Pat Beyer is 50%.
    What is the average return per transaction made by Pat Beyer?
    The average return per transaction made by Pat Beyer is 15.60%.
      What stocks does Pat Beyer hold?
      Pat Beyer holds: CNMD, MSON, BVS stocks.
        What was Pat Beyer’s latest transaction?
        Pat Beyer latest transaction was an Informative Buy of $204.90K.
          What was Pat Beyer's most profitable transaction?
          Pat Beyer’s most profitable transaction was an Informative Sell of CNMD stock on November 5, 2021. The return on the trade was 51.10%.
            What is Pat Beyer's role in Conmed?
            Pat Beyer's role in Conmed is President & CEO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.